BRIEF-Arcellx Announces Presentation Of New Clinical Data From Its Cart-Ddbcma Phase 1 Trial In Patients With Relapsed Or Refractory Multiple Myeloma At The 64Th Ash Annual Meeting And Exposition

Reuters · 11/03/2022 15:03
BRIEF-Arcellx Announces Presentation Of New Clinical Data From Its Cart-Ddbcma Phase 1 Trial In Patients With Relapsed Or Refractory Multiple Myeloma At The 64Th Ash Annual Meeting And Exposition

- Arcellx Inc ACLX.O:

  • ARCELLX ANNOUNCES PRESENTATION OF NEW CLINICAL DATA FROM ITS CART-DDBCMA PHASE 1 TRIAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AT THE 64TH ASH ANNUAL MEETING AND EXPOSITION

Source text for Eikon: ID:

Further company coverage: ACLX.O


((Reuters.Briefs@thomsonreuters.com;;))